These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16757684)
1. In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin. Nie G; Chen G; Sheftel AD; Pantopoulos K; Ponka P Blood; 2006 Oct; 108(7):2428-34. PubMed ID: 16757684 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Nie G; Sheftel AD; Kim SF; Ponka P Blood; 2005 Mar; 105(5):2161-7. PubMed ID: 15522954 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism. Lu Z; Nie G; Li Y; Soe-Lin S; Tao Y; Cao Y; Zhang Z; Liu N; Ponka P; Zhao B Antioxid Redox Signal; 2009 Aug; 11(8):1791-803. PubMed ID: 19271990 [TBL] [Abstract][Full Text] [Related]
4. Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. Zhang Y; Mikhael M; Xu D; Li Y; Soe-Lin S; Ning B; Li W; Nie G; Zhao Y; Ponka P Antioxid Redox Signal; 2010 Oct; 13(7):999-1009. PubMed ID: 20406137 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress. You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease. Shi ZH; Nie G; Duan XL; Rouault T; Wu WS; Ning B; Zhang N; Chang YZ; Zhao BL Antioxid Redox Signal; 2010 Sep; 13(6):783-96. PubMed ID: 20121342 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial ferritin: a new player in iron metabolism. Drysdale J; Arosio P; Invernizzi R; Cazzola M; Volz A; Corsi B; Biasiotto G; Levi S Blood Cells Mol Dis; 2002; 29(3):376-83. PubMed ID: 12547228 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation. Santambrogio P; Erba BG; Campanella A; Cozzi A; Causarano V; Cremonesi L; Gallì A; Della Porta MG; Invernizzi R; Levi S Haematologica; 2011 Oct; 96(10):1424-32. PubMed ID: 21712541 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial ferritin attenuates β-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways. Wu WS; Zhao YS; Shi ZH; Chang SY; Nie GJ; Duan XL; Zhao SM; Wu Q; Yang ZL; Zhao BL; Chang YZ Antioxid Redox Signal; 2013 Jan; 18(2):158-69. PubMed ID: 22746342 [TBL] [Abstract][Full Text] [Related]
10. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. Corsi B; Cozzi A; Arosio P; Drysdale J; Santambrogio P; Campanella A; Biasiotto G; Albertini A; Levi S J Biol Chem; 2002 Jun; 277(25):22430-7. PubMed ID: 11953424 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of mitochondrial ferritin on cytosolic iron dysregulation induced by doxorubicin in HeLa cells. Cocco E; Porrini V; Derosas M; Nardi V; Biasiotto G; Maccarinelli F; Zanella I Mol Biol Rep; 2013 Dec; 40(12):6757-64. PubMed ID: 24065548 [TBL] [Abstract][Full Text] [Related]
12. Chloramphenicol-induced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE-IRP interactions. Leiter LM; Thatte HS; Okafor C; Marks PW; Golan DE; Bridges KR J Cell Physiol; 1999 Sep; 180(3):334-44. PubMed ID: 10430173 [TBL] [Abstract][Full Text] [Related]
13. Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase. Frey AG; Nandal A; Park JH; Smith PM; Yabe T; Ryu MS; Ghosh MC; Lee J; Rouault TA; Park MH; Philpott CC Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8031-6. PubMed ID: 24843120 [TBL] [Abstract][Full Text] [Related]
14. Differences in vulnerability of neurons and astrocytes to heme oxygenase-1 modulation: Implications for mitochondrial ferritin. Yu X; Song N; Guo X; Jiang H; Zhang H; Xie J Sci Rep; 2016 Apr; 6():24200. PubMed ID: 27097841 [TBL] [Abstract][Full Text] [Related]
15. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Arosio P; Levi S Biochim Biophys Acta; 2010 Aug; 1800(8):783-92. PubMed ID: 20176086 [TBL] [Abstract][Full Text] [Related]
16. The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. Zanella I; Derosas M; Corrado M; Cocco E; Cavadini P; Biasiotto G; Poli M; Verardi R; Arosio P Biochim Biophys Acta; 2008 Feb; 1782(2):90-8. PubMed ID: 18160053 [TBL] [Abstract][Full Text] [Related]
17. Regulation of expression of ferritin H-chain and transferrin receptor by protoporphyrin IX. Coccia EM; Perrotti E; Stellacci E; Orsatti R; Del Russo N; Marziali G; Testa U; Battistini A Eur J Biochem; 1997 Dec; 250(3):764-72. PubMed ID: 9461300 [TBL] [Abstract][Full Text] [Related]
18. 2,3,7,8-Tetrachlorodibenzo-p-dioxin impairs iron homeostasis by modulating iron-related proteins expression and increasing the labile iron pool in mammalian cells. Santamaria R; Fiorito F; Irace C; De Martino L; Maffettone C; Granato GE; Di Pascale A; Iovane V; Pagnini U; Colonna A Biochim Biophys Acta; 2011 May; 1813(5):704-12. PubMed ID: 21333694 [TBL] [Abstract][Full Text] [Related]
19. Nickel decreases cellular iron level and converts cytosolic aconitase to iron-regulatory protein 1 in A549 cells. Chen H; Davidson T; Singleton S; Garrick MD; Costa M Toxicol Appl Pharmacol; 2005 Aug; 206(3):275-87. PubMed ID: 16039939 [TBL] [Abstract][Full Text] [Related]
20. PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis. Ryu MS; Zhang D; Protchenko O; Shakoury-Elizeh M; Philpott CC J Clin Invest; 2017 May; 127(5):1786-1797. PubMed ID: 28375153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]